Furthermore, 200 decreased tau phosphorylation and PKC activity in a human neuroblastoma cell line, thus being a good inhibitor of tau protein-induced neurotoxicity (Figure 24) [190]. The gene discussed is MAPT; the disease is neuroblastoma.